California's Proposition 65 gives its consumers the right to know whether they may be exposed to certain chemicals. But ...

As the planet warms, a new wave of PhD founders is emerging to tackle the crisis with deeptech solutions, spinning out ...

Bluejay's lead product candidate brelovitug (BJT-778) recently received U.S. Food and Drug Administration (FDA) Breakthrough Therapy designation for the treatment of chronic hepatitis delta (CHD).

AI Proteins, Inc., a pioneering company utilizing artificial intelligence to design novel miniprotein therapeutics, today announced the appointment of Dr. Philip E. Brandish, PhD as Chief Development ...

Collaboration will combine AbbVie's oncology expertise and Xilio's proprietary tumor-activation technology to develop novel immunotherapies, including masked T-cell engagersXilio to host investor ...

The Value-chain Innovation for Sustainable Transformation in Agrarian Reform Communities (VISTA) Project of the Department of ...